Product Code: ETC8845834 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The market for minor cannabinoids, including CBG and CBN, is emerging in the Philippines as research into their therapeutic benefits grows. While regulatory challenges remain, increasing awareness of alternative medicine and wellness trends is shaping demand. The development of cannabinoid-based supplements and skincare products is expanding market opportunities.
The minor cannabinoids market in the Philippines is emerging as research into cannabis-derived compounds expands. Compounds such as CBG, CBN, and CBC are gaining attention for their potential therapeutic benefits, including anti-inflammatory and neuroprotective properties. The market is driven by increasing consumer interest in wellness and alternative medicine. However, regulatory restrictions and public perception challenges may slow growth.
The market for minor cannabinoids in the Philippines faces significant legal and regulatory challenges. Strict government restrictions on cannabis-related products create barriers to market entry and expansion. There is also limited consumer awareness and acceptance of minor cannabinoids, as stigma surrounding cannabis use persists. Additionally, sourcing high-quality raw materials remains difficult due to a lack of local cultivation and reliance on expensive imports.
The Philippine market for minor cannabinoids, including CBG and CBN, is expanding due to increasing awareness of their potential health benefits. Investment opportunities exist in cannabinoid extraction, research and development, and medicinal product manufacturing. Regulatory compliance and partnerships with healthcare providers can enhance market entry.
Dangerous Drugs Board (DDB). Policies ensure that cannabinoid products comply with medical and safety standards. The government strictly monitors the sale and distribution of cannabinoid-based products. Research initiatives are supported to explore potential medical benefits under controlled conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Minor Cannabinoids Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Minor Cannabinoids Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Minor Cannabinoids Market - Industry Life Cycle |
3.4 Philippines Minor Cannabinoids Market - Porter's Five Forces |
3.5 Philippines Minor Cannabinoids Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Minor Cannabinoids Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Minor Cannabinoids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the potential health benefits of minor cannabinoids in the Philippines |
4.2.2 Growing acceptance of alternative medicine and natural remedies in the market |
4.2.3 Favorable government regulations supporting the cultivation and use of minor cannabinoids |
4.3 Market Restraints |
4.3.1 Limited research and information available on the efficacy and safety of minor cannabinoids |
4.3.2 High production costs associated with cultivating and extracting minor cannabinoids in the Philippines |
5 Philippines Minor Cannabinoids Market Trends |
6 Philippines Minor Cannabinoids Market, By Types |
6.1 Philippines Minor Cannabinoids Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Minor Cannabinoids Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Philippines Minor Cannabinoids Market Revenues & Volume, By Cannabigerol, 2021- 2031F |
6.1.4 Philippines Minor Cannabinoids Market Revenues & Volume, By Cannabichromene, 2021- 2031F |
6.1.5 Philippines Minor Cannabinoids Market Revenues & Volume, By Cannabinol, 2021- 2031F |
6.1.6 Philippines Minor Cannabinoids Market Revenues & Volume, By Tetrahydrocannabivarin, 2021- 2031F |
6.2 Philippines Minor Cannabinoids Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Minor Cannabinoids Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.2.3 Philippines Minor Cannabinoids Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.4 Philippines Minor Cannabinoids Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.5 Philippines Minor Cannabinoids Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.6 Philippines Minor Cannabinoids Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Minor Cannabinoids Market Import-Export Trade Statistics |
7.1 Philippines Minor Cannabinoids Market Export to Major Countries |
7.2 Philippines Minor Cannabinoids Market Imports from Major Countries |
8 Philippines Minor Cannabinoids Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on minor cannabinoids in the Philippines |
8.2 Percentage increase in the adoption of minor cannabinoids in the healthcare sector |
8.3 Growth in the number of licensed producers and suppliers of minor cannabinoids in the Philippines |
9 Philippines Minor Cannabinoids Market - Opportunity Assessment |
9.1 Philippines Minor Cannabinoids Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Minor Cannabinoids Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Minor Cannabinoids Market - Competitive Landscape |
10.1 Philippines Minor Cannabinoids Market Revenue Share, By Companies, 2024 |
10.2 Philippines Minor Cannabinoids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |